Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing elderly female population
3.2.1.2 Rising health consciousness and consumer interest in active living
3.2.1.3 Rising prevalence of chronic disease among women
3.2.1.4 Emergence of online platforms for women’s health supplements
3.2.1.5 Increasing women’s awareness about the benefits of health supplements
3.2.2 Industry pitfalls & challenges
3.2.2.1 Presence of counterfeit products
3.2.2.2 Lack of regulations
3.3 Growth potential analysis
3.4 Porter’s analysis
3.4.1 Supplier power
3.4.2 Buyer power
3.4.3 Threat of new entrants
3.4.4 Threat of substitutes
3.4.5 Industry rivalry
3.5 PESTEL analysis
3.6 Pricing analysis, 2023
3.7 Future market trends
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Vitamins & minerals
5.3 Botanicals
5.4 Proteins & amino acids
5.5 Probiotics & enzymes
5.6 Omega-3
5.7 Other products
Chapter 6 Market Estimates and Forecast, By Form, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Tablet & capsule
6.3 Powder
6.4 Solutions
Chapter 7 Market Estimates and Forecast, By Supplement Type, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Over-the-counter (OTC)
7.3 Prescription
Chapter 8 Market Estimates and Forecast, By Age Group, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 15-30
8.3 31-50
8.4 51-70
8.5 Above age 70
Chapter 9 Market Estimates and Forecast, By Consumer Group, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 Prenatal
9.3 Postnatal
9.4 Premenstrual syndrome
9.5 Perimenopausal
9.6 Postmenopausal
9.7 Other consumer groups
Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2018 – 2032 ($ Mn)
10.1 Key trends
10.2 Hypermarkets/ supermarkets
10.3 Pharmacies/drug stores
10.4 Retail stores
10.5 Online sales channels
Chapter 11 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
11.1 Key trends
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Spain
11.3.5 Italy
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 Middle East and Africa
11.6.1 South Africa
11.6.2 Saudi Arabia
11.6.3 Rest of Middle East and Africa
Chapter 12 Company Profiles
12.1 Abbott
12.2 Amway
12.3 Bayer AG
12.4 Designs for Health, Inc.
12.5 Dr. Reddy's Laboratories Ltd.
12.6 Herbalife International of America, Inc.
12.7 HUM Nutrition
12.8 Nutraceutical Corporation
12.9 Pfizer, Inc.
12.10 Procter & Gamble
12.11 Quantum Health
12.12 Revital Ltd.
12.13 Taisho Pharmaceutical
12.14 Vital Proteins
